We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2010 by Seoul National University Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00501475
First Posted: July 16, 2007
Last Update Posted: July 27, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Seoul National University Hospital
July 13, 2007
July 16, 2007
July 27, 2010
March 2007
Not Provided
the rate of CIN [ Time Frame: 3 days after CT scan ]
Same as current
Complete list of historical versions of study NCT00501475 on ClinicalTrials.gov Archive Site
mortality [ Time Frame: 30 days after CT scan ]
Same as current
Not Provided
Not Provided
 
NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED
Not Provided
The purpose of this study is to evaluate the effect of NAC or sodium bicarbonate in preventing the aggravation of renal function in chronic renal failure when enhanced computed tomography scan is checked in emergency room.

CIN is frequent in CRF patients. However most studies about CIN has been focusing on elective PCI patients. There is no study that the NAC nor sodium bicarbonate would help in preventing CIN in CRF patients who need enhanced CT scan in ED.

Our intention was to investigate the effect of NAC or sodium bicarbonate in preventing the aggravation of renal function in chronic renal failure when enhanced computed tomography scan is checked in emergency room.

Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Prevention
Chronic Renal Failure
Drug: NAC Bicarbonate
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
Not Provided
October 2010
Not Provided

Inclusion Criteria:

  • CRF patients who need enhanced CT scan

Exclusion Criteria:

  • less than 15 years old
  • hypersensitivity to NAC
  • on dialysis
  • no consent from patient or next of kin
Sexes Eligible for Study: All
15 Years and older   (Child, Adult, Senior)
Not Provided
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT00501475
06-2006-084
No
Not Provided
Not Provided
Not Provided
Seoul National University Hospital
Not Provided
Principal Investigator: Kyuseok Kim, MD Seoul National University Bundang Hospital
Seoul National University Hospital
July 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP